Hologic Stock News

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference.

Hologic, Inc. (NASDAQ:HOLX ) Q3 2024 Earnings Conference Call July 29, 2024 4:30 AM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President & CEO Essex Mitchell - COO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Jack Meehan - Nephron Research Vijay Kumar - Evercore Anthony Petrone - Mizuho Securities Michael...

Medical technology company Hologic reported a higher third-quarter profit on Monday, driven by strong demand for its diagnostics and breast health products, but forecast revenue for the current quarter that fell short of Wall Street estimates.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #HGWHI--72 Million American Women Have Skipped or Delayed Vital Screenings.

The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's devices that are implanted in soft tissue such as breast tissue as "most serious".

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic to Webcast Presentations at Upcoming Investor Conferences.

Hologic's women's health business benefited from the pandemic but is now facing headwinds that will end in 2024. The company has a strong balance sheet, solid track record, and reasonable valuation, making it an attractive investment. Hologic recently made another bolt-on acquisition and expects organic sales to grow by 5-7%, leading to potential valuation expansion.

Call Start: 16:30 January 1, 0000 5:24 PM ET Hologic, Inc. (NASDAQ:HOLX ) Q2 2024 Earnings Conference Call May 2, 2024 16:30 ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President & Chief Executive Officer Essex Mitchell - Chief Operating Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi ...